It was reported a patient underwent a cardiac ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and patient experienced esophageal vagus nerve disorder post ablation procedure.It was initially reported that the patient experienced esophageal vagus nerve disorder after completion of procedure.Patient has recovered and physician assessment is non-serious (moderate/minor).No interventions required.As such, the event was assessed as a patient event non-serious and non-mdr reportable.On 8-mar-2024, additional information was received indicating that after the procedure, esophageal vagus nerve disorder occurred.Acute gastric dilatation developed because of vagus nerve disorder, and drainage was performed using a nasogastric tube.Fully recovered 1 week after the procedure, and the patient has been discharged from the hospital.No catheter defects reported.No error messages were observed on bwi equipment.The physician commented that the product malfunctions and excessive ablations were unlikely.
|
Device investigation details: information received indicates that the device is not available for return, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device number lot: 31215221l and no internal action related to the complaint was found during the review.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.E1.Initial reporter phone: (b)(6).If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref#: (b)(4).
|
On 22-apr-2024, additional information was received indicating the correct lot number involved in this incident is 30844097l.As such, field d4 lot has been updated along with the appropriate manufactured date and expiration date fields.A manufacturing record evaluation was performed for the finished device number lot 30844097l and no internal action related to the complaint was found during the review.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|